Drug Development Testing Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512243862

Publication Date:

December 6, 2024

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Drug development can be divided into four phases: discovery, preclinical studies, clinical development and market approval.The Drug Discovery Process involves many different stages and series of actions. Lab-based drug tests are more accurate. We like to say they are more rigorous, more involved, and more defensible in a court of law, all of which are elements certain organizations must consider, particularly heavily regulated industries, like the DOT.
The global market for Drug Development Testing Services was estimated to be worth US$ 578 million in 2023 and is forecast to a readjusted size of US$ 888.9 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Development Testing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Development Testing Services by region & country, by Type, and by Application.
The Drug Development Testing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Development Testing Services.
麻豆原创 Segmentation
By Company
Pacific BioLabs
Catalent
ICON
ProPharma Group
WuXi AppTec
Labcorp
MedPharm
Patheon
CTI
Thermo Fisher
ChemPartner
Frontage Labs
ChemDiv
Segment by Type:
In Vivo Services
Bio Chemistry Analytical
Microbiology Analytical
Others
Segment by Application
Drug Development
Clinical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Development Testing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Development Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Development Testing Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Drug Development Testing Services Product Introduction
1.2 Global Drug Development Testing Services 麻豆原创 Size Forecast
1.3 Drug Development Testing Services 麻豆原创 Trends & Drivers
1.3.1 Drug Development Testing Services Industry Trends
1.3.2 Drug Development Testing Services 麻豆原创 Drivers & Opportunity
1.3.3 Drug Development Testing Services 麻豆原创 Challenges
1.3.4 Drug Development Testing Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Development Testing Services Players Revenue Ranking (2023)
2.2 Global Drug Development Testing Services Revenue by Company (2019-2024)
2.3 Key Companies Drug Development Testing Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Development Testing Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Development Testing Services
2.6 Drug Development Testing Services 麻豆原创 Competitive Analysis
2.6.1 Drug Development Testing Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug Development Testing Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Development Testing Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 In Vivo Services
3.1.2 Bio Chemistry Analytical
3.1.3 Microbiology Analytical
3.1.4 Others
3.2 Global Drug Development Testing Services Sales Value by Type
3.2.1 Global Drug Development Testing Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Development Testing Services Sales Value, by Type (2019-2030)
3.2.3 Global Drug Development Testing Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Development
4.1.2 Clinical Research
4.1.3 Others
4.2 Global Drug Development Testing Services Sales Value by Application
4.2.1 Global Drug Development Testing Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Development Testing Services Sales Value, by Application (2019-2030)
4.2.3 Global Drug Development Testing Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug Development Testing Services Sales Value by Region
5.1.1 Global Drug Development Testing Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Development Testing Services Sales Value by Region (2019-2024)
5.1.3 Global Drug Development Testing Services Sales Value by Region (2025-2030)
5.1.4 Global Drug Development Testing Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug Development Testing Services Sales Value, 2019-2030
5.2.2 North America Drug Development Testing Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug Development Testing Services Sales Value, 2019-2030
5.3.2 Europe Drug Development Testing Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug Development Testing Services Sales Value, 2019-2030
5.4.2 Asia Pacific Drug Development Testing Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug Development Testing Services Sales Value, 2019-2030
5.5.2 South America Drug Development Testing Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug Development Testing Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug Development Testing Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Development Testing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Development Testing Services Sales Value
6.3 United States
6.3.1 United States Drug Development Testing Services Sales Value, 2019-2030
6.3.2 United States Drug Development Testing Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Development Testing Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Development Testing Services Sales Value, 2019-2030
6.4.2 Europe Drug Development Testing Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Development Testing Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Development Testing Services Sales Value, 2019-2030
6.5.2 China Drug Development Testing Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Development Testing Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Development Testing Services Sales Value, 2019-2030
6.6.2 Japan Drug Development Testing Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Development Testing Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Development Testing Services Sales Value, 2019-2030
6.7.2 South Korea Drug Development Testing Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Development Testing Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Development Testing Services Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Development Testing Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Development Testing Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Development Testing Services Sales Value, 2019-2030
6.9.2 India Drug Development Testing Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Development Testing Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pacific BioLabs
7.1.1 Pacific BioLabs Profile
7.1.2 Pacific BioLabs Main Business
7.1.3 Pacific BioLabs Drug Development Testing Services Products, Services and Solutions
7.1.4 Pacific BioLabs Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.1.5 Pacific BioLabs Recent Developments
7.2 Catalent
7.2.1 Catalent Profile
7.2.2 Catalent Main Business
7.2.3 Catalent Drug Development Testing Services Products, Services and Solutions
7.2.4 Catalent Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.2.5 Catalent Recent Developments
7.3 ICON
7.3.1 ICON Profile
7.3.2 ICON Main Business
7.3.3 ICON Drug Development Testing Services Products, Services and Solutions
7.3.4 ICON Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.3.5 ProPharma Group Recent Developments
7.4 ProPharma Group
7.4.1 ProPharma Group Profile
7.4.2 ProPharma Group Main Business
7.4.3 ProPharma Group Drug Development Testing Services Products, Services and Solutions
7.4.4 ProPharma Group Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.4.5 ProPharma Group Recent Developments
7.5 WuXi AppTec
7.5.1 WuXi AppTec Profile
7.5.2 WuXi AppTec Main Business
7.5.3 WuXi AppTec Drug Development Testing Services Products, Services and Solutions
7.5.4 WuXi AppTec Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.5.5 WuXi AppTec Recent Developments
7.6 Labcorp
7.6.1 Labcorp Profile
7.6.2 Labcorp Main Business
7.6.3 Labcorp Drug Development Testing Services Products, Services and Solutions
7.6.4 Labcorp Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.6.5 Labcorp Recent Developments
7.7 MedPharm
7.7.1 MedPharm Profile
7.7.2 MedPharm Main Business
7.7.3 MedPharm Drug Development Testing Services Products, Services and Solutions
7.7.4 MedPharm Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.7.5 MedPharm Recent Developments
7.8 Patheon
7.8.1 Patheon Profile
7.8.2 Patheon Main Business
7.8.3 Patheon Drug Development Testing Services Products, Services and Solutions
7.8.4 Patheon Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.8.5 Patheon Recent Developments
7.9 CTI
7.9.1 CTI Profile
7.9.2 CTI Main Business
7.9.3 CTI Drug Development Testing Services Products, Services and Solutions
7.9.4 CTI Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.9.5 CTI Recent Developments
7.10 Thermo Fisher
7.10.1 Thermo Fisher Profile
7.10.2 Thermo Fisher Main Business
7.10.3 Thermo Fisher Drug Development Testing Services Products, Services and Solutions
7.10.4 Thermo Fisher Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.10.5 Thermo Fisher Recent Developments
7.11 ChemPartner
7.11.1 ChemPartner Profile
7.11.2 ChemPartner Main Business
7.11.3 ChemPartner Drug Development Testing Services Products, Services and Solutions
7.11.4 ChemPartner Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.11.5 ChemPartner Recent Developments
7.12 Frontage Labs
7.12.1 Frontage Labs Profile
7.12.2 Frontage Labs Main Business
7.12.3 Frontage Labs Drug Development Testing Services Products, Services and Solutions
7.12.4 Frontage Labs Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.12.5 Frontage Labs Recent Developments
7.13 ChemDiv
7.13.1 ChemDiv Profile
7.13.2 ChemDiv Main Business
7.13.3 ChemDiv Drug Development Testing Services Products, Services and Solutions
7.13.4 ChemDiv Drug Development Testing Services Revenue (US$ Million) & (2019-2024)
7.13.5 ChemDiv Recent Developments
8 Industry Chain Analysis
8.1 Drug Development Testing Services Industrial Chain
8.2 Drug Development Testing Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Development Testing Services Sales Model
8.5.2 Sales Channel
8.5.3 Drug Development Testing Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Pacific BioLabs
Catalent
ICON
ProPharma Group
WuXi AppTec
Labcorp
MedPharm
Patheon
CTI
Thermo Fisher
ChemPartner
Frontage Labs
ChemDiv

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.